236 related articles for article (PubMed ID: 20832130)
1. Price and welfare effects of a pharmaceutical substitution reform.
Granlund D
J Health Econ; 2010 Dec; 29(6):856-65. PubMed ID: 20832130
[TBL] [Abstract][Full Text] [Related]
2. Impact of a generic substitution reform on patients' and society's expenditure for pharmaceuticals.
Andersson K; Bergström G; Petzold MG; Carlsten A
Health Policy; 2007 May; 81(2-3):376-84. PubMed ID: 16945449
[TBL] [Abstract][Full Text] [Related]
3. The effect of generic competition on the price of brand-name drugs.
Lexchin J
Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552
[TBL] [Abstract][Full Text] [Related]
4. Competition between brand-name and generics--analysis on pricing of brand-name pharmaceutical.
Kong Y
Health Econ; 2009 May; 18(5):591-606. PubMed ID: 18816580
[TBL] [Abstract][Full Text] [Related]
5. Authorized generic drugs, price competition, and consumers' welfare.
Berndt ER; Mortimer R; Bhattacharjya A; Parece A; Tuttle E
Health Aff (Millwood); 2007; 26(3):790-9. PubMed ID: 17485758
[TBL] [Abstract][Full Text] [Related]
6. Do pharmaceutical prices respond to potential patient out-of-pocket expenses?
Pavenik N
Rand J Econ; 2002; 33(3):469-87. PubMed ID: 12585303
[TBL] [Abstract][Full Text] [Related]
7. Price regulation and generic competition in the pharmaceutical market.
Dalen DM; Strøm S; Haabeth T
Eur J Health Econ; 2006 Sep; 7(3):208-14. PubMed ID: 16841230
[TBL] [Abstract][Full Text] [Related]
8. The strategic response by pharmaceutical firms to the Medicaid most-favored-customer rules.
Scott Morton F
Rand J Econ; 1997; 28(2):269-90. PubMed ID: 11794358
[TBL] [Abstract][Full Text] [Related]
9. Parallel imports and a mandatory substitution reform: a kick or a muff for price competition in pharmaceuticals?
Granlund D; Koksal-Ayhan MY
Eur J Health Econ; 2015 Dec; 16(9):969-83. PubMed ID: 25404013
[TBL] [Abstract][Full Text] [Related]
10. Why drug prices will go lower.
Tully S
Fortune; 1993 May; 127(9):56-8, 60, 62 passim. PubMed ID: 10125261
[TBL] [Abstract][Full Text] [Related]
11. The impact of generic substitution on price competition in Finland.
Aalto-Setälä V
Eur J Health Econ; 2008 May; 9(2):185-91. PubMed ID: 17508226
[TBL] [Abstract][Full Text] [Related]
12. Price competition in pharmaceuticals - Evidence from 1303 Swedish markets.
Granlund D; Bergman MA
J Health Econ; 2018 Sep; 61():1-12. PubMed ID: 30007260
[TBL] [Abstract][Full Text] [Related]
13. Effect of generic drug competition on the price of prescription drugs in Ontario.
Lexchin J
CMAJ; 1993 Jan; 148(1):35-8. PubMed ID: 8439888
[TBL] [Abstract][Full Text] [Related]
14. Are private physicians more likely to veto generic substitution of prescribed pharmaceuticals?
Granlund D
Soc Sci Med; 2009 Dec; 69(11):1643-50. PubMed ID: 19815322
[TBL] [Abstract][Full Text] [Related]
15. Does generic entry lower the prices paid for pharmaceuticals in Australia? A comparison before and after the introduction of the mandatory price-reduction policy.
Spinks J; Chen G; Donovan L
Aust Health Rev; 2013 Nov; 37(5):675-81. PubMed ID: 24160374
[TBL] [Abstract][Full Text] [Related]
16. Generic script share and the price of brand-name drugs: the role of consumer choice.
Rizzo JA; Zeckhauser R
Int J Health Care Finance Econ; 2009 Sep; 9(3):291-316. PubMed ID: 19130220
[TBL] [Abstract][Full Text] [Related]
17. Physicians' opinions and experiences of the Pharmaceutical Benefits Reform.
Andersson K; Jörgensen T; Carlsten A
Scand J Public Health; 2006; 34(6):654-9. PubMed ID: 17132599
[TBL] [Abstract][Full Text] [Related]
18. Competition and the Reference Pricing Scheme for pharmaceuticals.
Ghislandi S
J Health Econ; 2011 Dec; 30(6):1137-49. PubMed ID: 21937137
[TBL] [Abstract][Full Text] [Related]
19. International experiences of promoting generics use and its implications to China.
Sun J
J Evid Based Med; 2013 May; 6(2):74-80. PubMed ID: 23829799
[TBL] [Abstract][Full Text] [Related]
20. Impact of the Minimum Pricing Policy and introduction of brand (generic) substitution into the Pharmaceutical Benefits Scheme in Australia.
McManus P; Birkett DJ; Dudley J; Stevens A
Pharmacoepidemiol Drug Saf; 2001; 10(4):295-300. PubMed ID: 11760489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
